Clinical Trial Update: A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) [Phase 2]

View source ↗

Summary

A Phase 2 continuation study of TAK-279 in adults with ulcerative colitis and Crohn's disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• TAK-279

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease, Ulcerative Colitis | Phase 2 | Status: RECRUITING